Common problems in bladder cancer: Evidence based debates


medac Satellite Symposium at the 34th Annual EAU Congress, Barcelona

Saturday, 16 March 2019
18:00 – 19:30 

Location: Green Area, Room 4
Chair: A. M.  Kamat, Houston (US)

18:00 - 18:10Introduction and case presentationsA.M. Kamat, 
Houston (US)
18:10 - 18:30Case-based debate 1P. Black,
Vancouver (CA)
Should all patients undergoing 1st time TURB receive immediate post-TURB chemotherapy instillation?H. Mostafid,
Guildford (GB)
18:30 - 18:50Case-based debate 2
High risk bladder cancer (TaHG with CIS): Is BCG induction sufficient?J. Bjerggaard Jensen,
Aarhus (DK)
M. Burger,
Regensburg (DE)
18:50 - 19:10Case-based debate 3
A patient with high risk bladder cancer (T1HG on TURBT,  repeat TUR negative) who cannot have radical cystectomy: Is BCG the best option?H. Mostafid,
Guildford (GB)
M. Burger,
Regensburg (DE)
19:10 - 19:20Common problems
Common Problem 1  
Recurrent low grade bladder tumor recurs after BCG/Chemotherapy - now what?
P. Black,
Vancouver (CA)

Common Problem 2 
How to prevent and manage BCG side effects
J. Bjerggaard Jensen,
Aarhus (DK)
19:20 - 19:30Discussion and closing remarksA.M. Kamat,
Houston (US)